Invention Grant
- Patent Title: BCMA antigen binding proteins
-
Application No.: US14649469Application Date: 2013-12-05
-
Publication No.: US10465009B2Publication Date: 2019-11-05
- Inventor: Richard J. Armitage , Michelle Blake , William C. Fanslow, III , Jason Charles O'Neill , Gunasekaran Kannan , Jiangchun Xu , Mark Edward Tometsko , Zhulun Wang , Athena Sudom
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Lawrence B. Kong
- International Application: PCT/US2013/073382 WO 20131205
- International Announcement: WO2014/089335 WO 20140612
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/48 ; A61K45/06 ; A61N5/10 ; A61K47/68 ; A61K39/00
Abstract:
The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
Public/Granted literature
- US20150344583A1 BCMA ANTIGEN BINDING PROTEINS Public/Granted day:2015-12-03
Information query
